In case you missed it: Oct. 11 to Oct. 15

Here's what you missed:

Effects of marijuana use on female reproductive health and pregnancy

As the landscape continues to shift, 3 experts offer guidance on how to advise patients who may want to use this substance.

What's next in anti-obesity and weight loss drugs?

Kara L. Marlatt, PhD, MPH, tells Contemporary OB/GYN® about the exciting new anti-obesity and weight loss drugs to watch for.

Nurse Barb Dehn: Vaccine hesitancy, S-equol, and women’s health in rural Africa

Barb Dehn, NP, discusses vaccine hesitancy, soy and estrogen receptors, and a hospital in Tanzania dedicated to improving women's health through quality health care and education in under-resourced communities.

FDA approves companion diagnostic for adjuvant abemaciclib plus endocrine therapy in high-risk early breast cancer

The FDA has approved the Ki-67 IHC MIB-1 pharmDx test to assist in determining which patients with early breast cancer who are at high risk of disease recurrence might benefit from adjuvant treatment with abemaciclib plus endocrine therapy.

The stigma around antibiotics for recurrent UTIs

According to guidelines, there is only 1 temporary cure for this condition and that is antibiotics. As more antibiotics are taken by this susceptible population, however, the bacteria can adapt and make recurrent UTI treatment in the future much more difficult.